Efficacy of combined gemcitabine, oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma

Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive neoplasm with a poor outcome. Asparaginase-based regimens are recommended for patients with advanced-stage or relapsed/refractory ENKTL. We retrospectively investigated the efficacy and toxicity of combined gemcitabine, oxaliplatin,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing-hua, Wang, Liang, Liu, Cheng-cheng, Xia, Zhong-jun, Huang, Hui-qiang, Lin, Tong-yu, Jiang, Wen-qi, Lu, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045380/
https://www.ncbi.nlm.nih.gov/pubmed/27093153
http://dx.doi.org/10.18632/oncotarget.8647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045380/
https://www.ncbi.nlm.nih.gov/pubmed/27093153
http://dx.doi.org/10.18632/oncotarget.8647

Ejemplares similares